НОВАЯ СТАТЬЯ
Rituximab intervention in management of thrombocytopenia in patients with systemic lupus erythematosus: A single centre experience.
RTX demonstrates efficacy and safety for SLE patients with thrombocytopenia unresponsive to conventional treatments, offering a potential alternative, and reducing reliance on GCs and IVIG.